Biodexa Pharmaceuticals (5MP2) Cash flow

0 Followers

Biodexa Pharmaceuticals Cash Flow

DE:5MP2's free cash flow for Q2 2026 was £-4.62M. For the 2026 fiscal year, DE:5MP2's free cash flow was decreased by £7.64M and operating cash flow was £-4.62M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	£ -5.39M	£ -12.26M	£ -6.83M	£ -7.05M	£ -6.01M
Investing Cash Flow	£ -658.25K	£ -598.00K	£ -265.00K	£ -220.00K	£ -278.00K
Financing Cash Flow	£ 12.77M	£ 8.56M	£ 10.23M	£ 47.00K	£ 8.80M
End Cash Position	£ 8.52M	£ 1.67M	£ 5.97M	£ 2.84M	£ 10.06M
Free Cash Flow	£ -5.40M	£ -13.04M	£ -7.09M	£ -7.11M	£ -6.33M

Currency in GBP